#MDA2022 – CNM-Au8 May Slow Progression, Reduce Risk of Death
Treatment with Clene Nanomedicine’s experimental medicine CNM-Au8 may decrease the risk of disease progression or death in people with…
Articles by Marisa Wexler, MS
BMAA, Formaldehyde Among Toxins in Environment Linked to ALS Risk
Exposure to certain toxic compounds — including beta-N-methylamino-L-alanine (BMAA), formaldehyde, and heavy metals like manganese, mercury, and zinc — increases…
In FUS-ALS Cell Model, Circular RNA ‘Trapped’ in Toxic Protein Clumps
Mutations in the FUS gene, which cause some forms of amyotrophic lateral sclerosis (ALS), result in a circular RNA…
London-based CERF Prizes Benefit U.S.-based Research
The Cullen Education and Research Fund (CERF), a private philanthropy based in London, has awarded more than $800,000 to support…
Structure of TDP-43 Protein Clumps Identified for First Time
A team of scientists in the U.K. and Japan has determined the structure of aggregated TDP-43, the protein whose abnormal clumps…
Oral Edaravone Under FDA Priority Review, Decision Expected in May
A decision is expected by May from the U.S. Food and Drug Administration (FDA) on an application seeking approval of…
Top 10 ALS Stories of 2021
ALS News Today brought you daily coverage of the latest scientific breakthroughs and clinical research related to amyotrophic…
Risk of ALS Increases Nearly Fourfold in NFL Players
Athletes who have played in the National Football League (NFL) are significantly more likely than the general population to develop…
Gene Therapy Targeting Motor Neurons in Brain May Help Treat ALS
While it’s long been believed that the death of motor neurons in the spinal cord is the main cause of…
Tau Protein in Alzheimer’s Linked to ALS Mitochondrial Dysfunction
An abnormal version of tau, a protein associated with Alzheimer’s disease, may contribute to the progression of amyotrophic lateral…